Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1995 1
2006 1
2007 2
2008 2
2010 1
2011 2
2012 4
2013 3
2014 4
2015 5
2016 5
2017 3
2018 9
2019 10
2020 9
2021 9
2022 8
2023 9
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr. Sparano JA, et al. Among authors: badve ss. N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860917 Free PMC article. Clinical Trial.
Ductal carcinoma in situ of breast: update 2019.
Badve SS, Gökmen-Polar Y. Badve SS, et al. Pathology. 2019 Oct;51(6):563-569. doi: 10.1016/j.pathol.2019.07.005. Epub 2019 Aug 28. Pathology. 2019. PMID: 31472981 Free PMC article. Review.
Targeting the Tumor-Tumor Microenvironment Crosstalk.
Badve SS, Gökmen-Polar Y. Badve SS, et al. Expert Opin Ther Targets. 2023 Jan-Jun;27(6):447-457. doi: 10.1080/14728222.2023.2230362. Epub 2023 Jul 4. Expert Opin Ther Targets. 2023. PMID: 37395003 Review.
Fibroblastic sarcomas of the mediastinum.
Chen S, Badve SS. Chen S, et al. Among authors: badve ss. Mediastinum. 2020 Sep 30;4:26. doi: 10.21037/med-20-44. eCollection 2020. Mediastinum. 2020. PMID: 35118294 Free PMC article. Review.
AJCC 8th edition-A step forward.
Badve SS, Fisher C. Badve SS, et al. Breast J. 2020 Jul;26(7):1263-1264. doi: 10.1111/tbj.13907. Epub 2020 Jun 18. Breast J. 2020. PMID: 32558043 No abstract available.
A predictor of response in HER2+ breast cancer-at last!
Badve SS, Gökmen-Polar Y. Badve SS, et al. J Natl Cancer Inst. 2023 Mar 9;115(3):242-245. doi: 10.1093/jnci/djac228. J Natl Cancer Inst. 2023. PMID: 36576003 Free PMC article. No abstract available.
Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.
Sparano JA, Crager M, Gray RJ, Tang G, Hoag J, Baehner FL, Shak S, Makower DF, Albain KS, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Whelan TJ, Kaklamani VG, Wolmark N, Sledge GW, Stemmer SM. Sparano JA, et al. Among authors: badve ss. NEJM Evid. 2024 Aug;3(8):EVIDoa2300267. doi: 10.1056/EVIDoa2300267. Epub 2024 Jul 23. NEJM Evid. 2024. PMID: 39041867 Free PMC article.
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.
Geurts VCM, Balduzzi S, Steenbruggen TG, Linn SC, Siesling S, Badve SS, DeMichele A, Ignatiadis M, Leon-Ferre RA, Goetz MP, Wolff AC, Klar N, Michiels S, Loi S, Adams S, Horlings HM, Sonke GS, Salgado R, Kok M. Geurts VCM, et al. Among authors: badve ss. JAMA Oncol. 2024 Aug 1;10(8):1077-1086. doi: 10.1001/jamaoncol.2024.1917. JAMA Oncol. 2024. PMID: 38935352 Free PMC article.
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.
Rakha EA, Quinn C, Raymond W, Allison KH, Badve SS, Brogi E, Callagy G, Charafe-Jauffret E, Chen CJ, Chen YY, Collins LC, Cserni G, Djerroudi L, Jaffer S, Foschini MP, Gobbi H, Gudi M, Harada O, Kulka J, Kuroda H, Lakhani SR, Li X, Moriya T, O'Toole SA, Pinder SE, Provenzano E, Sahin AA, Schmitt F, Shaaban AM, Siziopikou KP, Tang P, Tse GM, Varga Z, Vincent-Salomon A, Wen H, Yamaguchi R, Yang W, Fox SB, Schnitt SJ, Ellis IO, Tan PH. Rakha EA, et al. Among authors: badve ss. Mod Pathol. 2025 May;38(5):100734. doi: 10.1016/j.modpat.2025.100734. Epub 2025 Feb 11. Mod Pathol. 2025. PMID: 39947480 Free article. Review.
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
Sparano JA, Gray RJ, Makower DF, Albain KS, Saphner TJ, Badve SS, Wagner LI, Kaklamani VG, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Toppmeyer DL, Brufsky AM, Goetz MP, Berenberg JL, Mahalcioiu C, Desbiens C, Hayes DF, Dees EC, Geyer CE Jr, Olson JA Jr, Wood WC, Lively T, Paik S, Ellis MJ, Abrams J, Sledge GW Jr. Sparano JA, et al. Among authors: badve ss. JAMA Oncol. 2020 Mar 1;6(3):367-374. doi: 10.1001/jamaoncol.2019.4794. JAMA Oncol. 2020. PMID: 31566680 Free PMC article. Clinical Trial.
91 results